TY - JOUR
T1 - Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy
T2 - KEYNOTE-087 subgroup analysis
AU - Zinzani, Pier Luigi
AU - Chen, Robert
AU - Armand, Philippe
AU - Johnson, Nathalie A.
AU - Brice, Pauline
AU - Radford, John
AU - Ribrag, Vincent
AU - Molin, Daniel
AU - Vassilakopoulos, Theodoros P.
AU - Tomita, Akihiro
AU - von Tresckow, Bastian
AU - Shipp, Margaret A.
AU - Lin, Jianxin
AU - Nahar, Akash
AU - Balakumaran, Arun
AU - Moskowitz, Craig H.
PY - 2020/3/20
Y1 - 2020/3/20
UR - http://www.scopus.com/inward/record.url?scp=85078638645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078638645&partnerID=8YFLogxK
U2 - 10.1080/10428194.2019.1702178
DO - 10.1080/10428194.2019.1702178
M3 - Letter
C2 - 31905294
AN - SCOPUS:85078638645
VL - 61
SP - 950
EP - 954
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 4
ER -